Literature DB >> 16847310

Type II nuclear hormone receptors, coactivator, and target gene repression in adipose tissue in the acute-phase response.

Biao Lu1, Arthur H Moser, Judy K Shigenaga, Kenneth R Feingold, Carl Grunfeld.   

Abstract

The acute-phase response (APR) leads to alterations in lipid metabolism and type II nuclear hormone receptors, which regulate lipid metabolism, are suppressed, in liver, heart, and kidney. Here, we examine the effect of the APR in adipose tissue. In mice, lipopolysaccharide produces a rapid, marked decrease in mRNA levels of nuclear hormone receptors [peroxisome proliferator-activated receptor gamma (PPARgamma), liver X receptor alpha (LXRalpha) and LXRbeta, thyroid receptor alpha (TRalpha) and TRbeta, and retinoid X receptor alpha (RXRalpha) and RXRbeta] and receptor coactivators [cAMP response element binding protein, steroid receptor coactivator 1 (SRC1) and SRC2, thyroid hormone receptor-associated protein, and peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC1alpha) and PGC1beta] along with decreased expression of target genes (adipocyte P2, phosphoenolpyruvate carboxykinase, glycerol-3-phosphate acyltransferase, ABCA1, apolipoprotein E, sterol-regulatory element binding protein-1c, glucose transport protein 4 (GLUT4), malic enzyme, and Spot14) involved in triglyceride (TG) and carbohydrate metabolism. We show that key TG synthetic enzymes, 1-acyl-sn-glycerol-3-phosphate acyltransferase-2, monoacylglycerol acyltransferase 1, and diacylglycerol acyltransferase 1, are PPARgamma-regulated genes and that they also decrease in the APR. In 3T3-L1 adipocytes, tumor necrosis factor-alpha (TNF-alpha) significantly decreases PPARgamma, LXRalpha and LXRbeta, RXRalpha and RXRbeta, SRC1 and SRC2, and PGC1alpha and PGC1beta mRNA levels, which are associated with a marked reduction in receptor-regulated genes. Moreover, TNF-alpha significantly reduces PPAR and LXR response element-driven transcription. Thus, the APR suppresses the expression of many nuclear hormone receptors and their coactivators in adipose tissue, which could be a mechanism to coordinately downregulate TG biosynthesis and thereby redirect lipids to other critical organs during the APR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847310     DOI: 10.1194/jlr.M500540-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  20 in total

1.  Inflammation inhibits GPR81 expression in adipose tissue.

Authors:  Kenneth R Feingold; Arthur Moser; Judy K Shigenaga; Carl Grunfeld
Journal:  Inflamm Res       Date:  2011-07-13       Impact factor: 4.575

2.  FGF21 is increased by inflammatory stimuli and protects leptin-deficient ob/ob mice from the toxicity of sepsis.

Authors:  Kenneth R Feingold; Carl Grunfeld; Josef G Heuer; Akanksha Gupta; Martin Cramer; Tonghai Zhang; Judy K Shigenaga; Sophie M Patzek; Zoe W Chan; Arthur Moser; Holly Bina; Alexei Kharitonenkov
Journal:  Endocrinology       Date:  2012-04-02       Impact factor: 4.736

3.  ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.

Authors:  Kai Yin; Duan-fang Liao; Chao-ke Tang
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

4.  Fatty acid-binding protein 5 limits the anti-inflammatory response in murine macrophages.

Authors:  Sherri M Moore; Vivian V Holt; Lillie R Malpass; Ian N Hines; Michael D Wheeler
Journal:  Mol Immunol       Date:  2015-06-20       Impact factor: 4.407

5.  Cardiolipin synthase-1 mRNA expression does not correlate with endogenous cardiolipin synthase enzyme activity in vitro and in vivo in mammalian lipopolysaccharide models of inflammation.

Authors:  Biao Lu; Fred Y Xu; William A Taylor; Kenneth R Feingold; Grant M Hatch
Journal:  Inflammation       Date:  2011-08       Impact factor: 4.092

6.  Enhanced Glucose Transport, but not Phosphorylation Capacity, Ameliorates Lipopolysaccharide-Induced Impairments in Insulin-Stimulated Muscle Glucose Uptake.

Authors:  Yolanda F Otero; Kimberly X Mulligan; Tammy M Barnes; Eric A Ford; Carlo M Malabanan; Haihong Zong; Jeffrey E Pessin; David H Wasserman; Owen P McGuinness
Journal:  Shock       Date:  2016-06       Impact factor: 3.454

Review 7.  Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?

Authors:  Ayse Bag-Ozbek; Jon T Giles
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.806

8.  Novel Therapeutic Agents in Pediatric Sepsis: Peroxisome Proliferator Receptor γ (PPAR γ) Agonists.

Authors:  Jennifer M Kaplan; Basilia Zingarelli
Journal:  Open Inflamm J       Date:  2011-10-07

9.  PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells.

Authors:  Wei-ming Wang; Hui-di Zhang; Yuan-meng Jin; Bing-bing Zhu; Nan Chen
Journal:  Acta Pharmacol Sin       Date:  2008-12-22       Impact factor: 6.150

10.  LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes.

Authors:  Biao Lu; Yang Lu; Arthur H Moser; Judy K Shigenaga; Carl Grunfeld; Kenneth R Feingold
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-21       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.